| Names | |
|---|---|
| Preferred IUPAC name | (2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl)(2,6-difluorobenzoyl)urea |
| Other names | Program LUF CGS 11779 NPO 10 Sentinel Conbantrin |
| Pronunciation | /luːˈfɛn.jʊˌrɒn/ |
| Identifiers | |
| CAS Number | 103055-07-8 |
| 3D model (JSmol) | `3d_jmol_viewer(structure=Lufenuron)` |
| Beilstein Reference | 120099 |
| ChEBI | CHEBI:6531 |
| ChEMBL | CHEMBL333731 |
| ChemSpider | 72302 |
| DrugBank | DB06779 |
| ECHA InfoCard | 03c1f113-11e4-4c1d-b50f-73236b2de4c7 |
| EC Number | 56081-54-0 |
| Gmelin Reference | 88048 |
| KEGG | C14412 |
| MeSH | D016923 |
| PubChem CID | 9836872 |
| RTECS number | OG7010000 |
| UNII | 67BF6TQS0I |
| UN number | UN3077 |
| Properties | |
| Chemical formula | C17H8Cl2F8N2O3 |
| Molar mass | 465.891 g/mol |
| Appearance | white crystalline powder |
| Odor | Odorless |
| Density | 1.68 g/cm³ |
| Solubility in water | 0.0006 g/L |
| log P | 4.26 |
| Vapor pressure | 4.3 × 10⁻⁷ mmHg (25 °C) |
| Acidity (pKa) | 13.9 |
| Basicity (pKb) | 14.65 |
| Magnetic susceptibility (χ) | -88.3×10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.560 |
| Dipole moment | 3.72 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 354.5 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -661.6 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -10810.7 kJ/mol |
| Pharmacology | |
| ATC code | QP53BX02 |
| Hazards | |
| Main hazards | May cause eye irritation; harmful if swallowed; may cause respiratory irritation. |
| GHS labelling | GHS07, GHS09 |
| Pictograms | GHS07, GHS09 |
| Signal word | Warning |
| Hazard statements | H410: Very toxic to aquatic life with long lasting effects. |
| Precautionary statements | Keep out of reach of children. Avoid contact with skin, eyes and clothing. Wash thoroughly after handling. Do not eat, drink or smoke when using this product. Avoid release to the environment. Collect spillage. |
| NFPA 704 (fire diamond) | 1-1-0-0 |
| Flash point | > 210 °C |
| Autoignition temperature | 375 °C |
| Lethal dose or concentration | LD50 oral rat: >5000 mg/kg |
| LD50 (median dose) | LD50 (median dose): 4,500 mg/kg (rat, oral) |
| PEL (Permissible) | 0.02 mg/kg |
| REL (Recommended) | 20 - 60 mg/kg |
| Related compounds | |
| Related compounds | Diflubenzuron Teflubenzuron Novaluron Chlorfluazuron |
| Category | Manufacturer Technical Commentary |
|---|---|
| Product Name | Lufenuron |
| IUPAC Name | (RS)-1-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]-3-(2,6-difluorobenzoyl)urea |
| Chemical Formula | C17H8Cl2F8N2O3 |
| CAS Number | 103055-07-8 |
| Synonyms & Trade Names | Lufenuron appears under various trade names depending on formulation and regional authorization. Typical synonyms include CGS-18409, Program, and Match. Actual commercial names used in finished product labeling often reflect knock-on requirements of local registration and downstream formulator preferences. Manufacturer is required to supply product references accurately in COA and batch documentation in line with client order instructions. |
| HS Code & Customs Classification | The HS code assignment for Lufenuron follows international customs conventions for agrochemical actives and pesticidal products. In most cases, Lufenuron is classified under HS Code 293299 (Other heterocyclic compounds with nitrogen hetero-atom(s) only), but this can shift based on formulation composition and intended use. The designation depends on manufacturing intent (technical material, premix, formulated end-use product) and receiving country's customs policies. Shipment documentation must align with up-to-date tariff schedules and regulatory interpretations of finished or technical grade status per shipment. |
Over the years, our production plants have processed Lufenuron in several technical grades, with raw material supply and process route varying to serve both animal health and crop protection markets. The identity section above reflects standard product understanding in the industrial sector; actual release criteria are routinely tailored to customer technical agreements and final application. Accurate trade name usage remains a point of regulatory focus in export documentation to satisfy traceability and secondary distribution records.
HS code decisions are handled in close consultation with our logistics, legal, and client compliance teams. Export batches may require submission of supporting documentation, where grade-specific differences—such as technical purity, isomer ratios, or proprietary formulation adjuvants—impact customs clearance. For buyers handling secondary processing or blending, it is important to reference both our master data and destination market requirements, as classification affects duties, registration pathways, and subsequent release to market.
All identification data remains subject to change according to evolving standards, updated regulatory guidance, or product stewardship requirements. Our technical department regularly verifies the accuracy of chemical identifiers against the newest international databases and in accordance with raw material traceability systems.
Lufenuron appears as a fine powder or crystalline solid in most technical grades, with the color ranging from off-white to pale yellow depending on trace impurities and formulation aids. The odor is typically faint to odorless if handled in a clean production environment. The melting point often varies by grade, with narrow range batches indicating higher purity. Density and particle characteristics depend strongly on crystallization and milling conditions during production. These features impact both storage flowability and downstream dispersion rates in formulations.
Lufenuron maintains its integrity under normal storage and handling temperatures used in chemical manufacturing. Under conditions of elevated temperature, extended exposure to moisture, or strong acid/base—especially in the presence of metal ions—degradation or hydrolysis can occur, with rates influenced by the formulation and storage container material. Our quality teams assess product stability during both accelerated aging and real-time trials, with outcome guiding recommended handling and packaging.
Solubility in water remains very low, which presents challenges in certain application settings. Organic solvents, particularly polar aprotic options like acetone or DMF, are used in technical solution preparation for analytical and process QA/QC. Solubility profiles differ with product grade due to minor variations in crystal habit and associated surface area. Mixing and agitation requirements for dispersal into carrier solvents are determined during batch release and application support testing.
Our specifications for lufenuron reflect both customer application (agrochemical, veterinary, or research) and regional compliance. Purity benchmarks, controlled by HPLC, guide batch release. Specifications for appearance, moisture, particle size distribution, residue on ignition, and assay are set by downstream formulation or regulatory requirement. Detailed specification sheets and certificates are issued per batch and grade.
Process-derived impurities, especially structural analogs and reaction intermediates, are monitored per batch. The main impurities typically arise from starting materials, incomplete conversion, and side-reactions during cyclization. Control of these impurities necessitates consistently high raw material quality and well-defined process parameters. Identification and quantification utilize validated chromatographic techniques. Impurity acceptance criteria are determined by application and regulatory demand, with collaborative review for custom grades.
Analytical methods, such as HPLC and GC where applicable, drive both in-process monitoring and final product testing. Calibration, reference standard qualification, and result reproducibility are reviewed by internal quality assurance. International guidance (such as FAO, USP, or local regulatory bodies) is referenced where available, but process-specific methods are established and validated in-house to reflect unique product and customer needs.
High-purity benzoylurea intermediates and chlorinated aromatic precursors form the base of our synthesis. Source reliability and traceability receive ongoing review to prevent introduction of variable impurities which could affect both process yield and final product stability. All suppliers undergo qualification audits that evaluate not only quality but supply-chain security and compliance.
The manufacturing route employs condensation followed by selective chlorination and carbamoylation steps. Catalyst choice, reagent molar ratios, and solvent selection derive from technical and scale-up optimization, balancing yield with impurity minimization. Process adjustments respond to raw material variability, guided by feedback from both process analytics and batch performance.
Critical process checkpoints include pH control during intermediate condensation, reaction time/temperature hold for key steps, and cascade extractions for final crude purification. Purification typically utilizes recrystallization, absorbing resins, or filtration, depending on targeted impurity removal for the required grade. Consistency across batches is monitored by both on-line and batch-end analytics, using rigorous documentation practices.
Batch release hinges on composite quality assessment: not only meeting exacting specification thresholds but also passing internal risk evaluation for unusual impurity patterns or process excursions. Customer-specific requirements or regulatory dossiers often drive further testing or packaging review prior to dispatch. All analytical data is archived for traceability.
Lufenuron can undergo hydrolysis under acidic or basic conditions leading to the breakup of the benzoylurea core and loss of biological function. Under specific synthetic protocols, the molecule serves as a platform for analog development by altering the aromatic or urea substitution patterns. This allows derivatization for both structure-activity relationship studies and new product development.
Process reaction conditions are tailored to maximize yield and minimize byproducts: catalysts and temperature are tuned by grade and batch scale. Industrial scale runs demand precise solvent control due to the solubility limitations and desired crystal form output. Reactions generating analogs or intermediates require strict secondary containment and occupational safety controls.
Benzoylurea derivatives retain the core structural element, enabling their use in synthesis of next-generation insect growth regulators. Chemical modifications depend on intended biological activity, with each new derivative undergoing full analytical profiling.
Lufenuron retains its technical integrity longest under dry, moderate temperature, and light-protected conditions. High humidity and direct UV lead to physical clumping or chemical degradation. Nitrogen-blanketed containers are sometimes used for sensitive formulations or bulk grades with low impurity tolerances.
Product is typically packaged in HDPE drums, lined fiber drums, or custom anti-static bags, selected after compatibility screening. Packaging is chosen based on permeability, risk of contamination, and resistance to solvent residues or trace acids.
Shelf life varies by grade and packaging. Crystallinity loss, caking, or the appearance of color shifts signal potential degradation. Periodic re-test protocols are implemented for stored bulk inventory, accompanied by ongoing analytical review to ensure material meets original batch specifications.
Lufenuron technical is classified based on hazard endpoints including acute oral, dermal, and inhalation toxicity, as well as aquatic risks. The exact classification reflects product purity and regional regulatory decisions; updated SDS are provided to all customers as part of batch documentation.
Production settings require engineering controls—such as dust extraction, closed transfer, and PPE—because powdered grades may pose inhalation risks; skin contact is minimized due to potential for mild irritation. Spillage is managed with containment and clean-up SOPs specific to plant configuration.
Acute and repeated dose studies inform operator safety management and packaging choices. Available data from guideline studies determine operational exposure limits and drive measures for environmental emission control, with all relevant information summarized in compliance with regulatory expectations.
Plant handling procedures align with available exposure limits, including personal monitoring and periodic health surveillance. Bulk loading, transfer, and formulation areas implement containment and dust monitoring strategies. All team members complete initial and periodic safety training, supported by visual communication of health risks and emergency actions throughout the facility.
Installed production of lufenuron runs in line with projected order flow, fluctuating mainly around seasonal application—influenced by agricultural calendar and end-user forecast. Large batch processes concentrate upstream, and practical annual outputs remain grade-dependent. Agro-industrial and veterinary grades dominate output allocation, echoed by higher volume availability before peak formulation periods. Inventory buildup does not usually extend into multi-season stocks; ongoing campaigns address firm orders to avoid long-term storage degradation or regulatory shelf-life risks.
Lead times track closely to active production cycle status. Standard lead time for fresh output is tied to batch closure, routine QA/QC, plus pre-shipment clearance. MOQ aligns to batch sizing, but can be reviewed for strategic or long-term partners, especially where multiple packaging configurations are specified. Customized MOQs for high-purity or value-added grades reflect upstream solvent and purification resource balancing.
Standard packaging includes fiber drums, HDPE drums, or multi-layer bags lined for solid bulk shipments. For technical, veterinary, or formulation-intermediate grades, specific anti-contamination packaging is implemented upon customer specification. Export-grade packaging is matched to maintain integrity under extended transit, with secondary containment as determined by destination regulatory or safety requirement.
Shipment terms reflect the buyer’s logistic preference: FOB, CIF, or FCA by sea, with full Bill of Lading and quality documentation upload before release. Advance payment and L/C terms usually depend on buyer history and credit profile. For sanctioned, restricted, or high-risk destinations, payments require additional compliance review in line with international trade controls.
Lufenuron pricing anchors to fluctuation in pyridine derivatives, halogenated intermediates, and solvent systems. Raw material costs move in sync with Chinese and Indian aromatic intermediates, plus market-driven volatility in fluoro and chloro reagents. Energy cost variations, environmental taxes, and compliance costs in upstream synthesis locales push direct influences on variable costs.
Raw material prices shift most noticeably with global crude fluctuations, regulatory clampdowns on specialty chemical plants (notably in China), or temporary force majeures in solvent supply chains. Unplanned shutdowns during regulatory audits have an immediate impact on cost base—often passed directly to contracted customers through escalated chemical input indexation. Feedstock-to-product traceability for high-purity or non-standard grades generates added premium.
Graded price differences reflect not only purity level but also analytical certification, batch documentation, and required regulatory compliance. Veterinary-grade lufenuron typically demands additional residue analysis, process impurity profiling, and final certification under national pharmacopoeia standards. Bulk agricultural grades focus on active content; unique packaging and global toxicology/certification for non-crop use force premiums. End-market registration costs embed further price differences—especially in developed economies.
Lufenuron remains dominated by China and India for technical-grade supply. Western regulatory focus (US, EU, JP) emphasizes animal health and specialty pest control, drawing technical supply but requiring graded segregation and certified traceability. Periodic demand spikes surface in response to pest outbreak regions, new regulatory approvals, or change in resistance pattern among target species.
| Region | Supply Characteristics | Demand Drivers |
|---|---|---|
| US | Prefers certified, documented supply chain. Veterinary and crop-residue registration drives cost. | Animal health, integrated pest management programs, acute regulatory scrutiny on residues. |
| EU | Strict lot-by-lot traceability; REACH and biocide approvals. Limited tolerance for impurities. | Veterinary, stored product protection, periodic market withdrawal, dynamic MRL regulation. |
| JP | Pharmacopoeial compliance, tight specification importers, stringent process validation. | Veterinary and domestic animal use; close monitoring of active content and contaminants. |
| IN | Bulk producer; local agro use, some export pre-processing. Moderately competitive pricing. | Field crop protection, pest resistance management, domestic price controls. |
| CN | Dominant upstream synthesis, environmental compliance impacts, heavy export orientation. | Technical production, global contract supply, sensitive to local policy shifts. |
Forward projection for lufenuron price shows moderate upward pressure, subject primarily to ongoing environmental control escalation in Chinese manufacturing, possible export quota restrictions, and expected consolidation among process license holders. Added synthesis scrutiny and increased regulatory hurdles for batch release (especially pharmacopoeial and food-crop routed grades) are driving higher compliance costs, which are expected to anchor the price above current short-term averages. Volatility remains possible if major feedstock or key intermediate plants undergo prolonged shutdown or face new policy enforcement cycles.
Price trend observations synthesize proprietary batch costing, upstream contract feedstock tracking, customer order history, and trade statistics published by certified customs authorities. Supply chain adjustments have been mapped through periodic supplier audits and shipment documentation review, including route-specific compliance factors under changing regulatory frameworks.
Ongoing environmental enforcement in major Chinese chemical zones disrupted continuous operation for several upstream intermediate producers. Some downstream buyers face unexpected lead time extension and new trace-level impurity specifications. International buyers reevaluate safety certification steps and adjust order cycles accordingly.
Expanded registration changes in the EU and selective states in the US recalibrated release testing for product intended for food-chain crops. New documentation requirements for batch traceability and in-use shelf-life data have pushed batch closure paperwork and certification load higher.
Manufacturing teams have prioritized real-time process monitoring points to flag impurity generation risks. Core purification strategies adapted to maintain lot-to-lot consistency, particularly for high-purity and veterinary-targeted batches. For key accounts requiring flexible packaging, integrated QA/QC checkpoints have been reinforced at each transfer step, addressing both product integrity and supply chain documentation precision. Forward contracts for sensitive intermediates and dual-sourcing propositions continue to serve as primary mitigation against raw material volatility and procurement disruption.
Lufenuron, a benzoylurea insect growth regulator, finds principal use in sectors including crop protection, animal health, and wood preservation. The production line for each segment responds to unique downstream demand for impurity profiles, solubility, formulation compatibility, and regulatory compliance.
| Application Segment | Suitable Grade(s) | Key Parameters Managed | Critical Control Points in Production |
|---|---|---|---|
| Crop Protection | Technical, Formulation | Active content, typical water content, known major organic impurities, compliance with local MRLs. Formulation compatibility, dispersibility, dustiness. | Batch-to-batch control for active content and impurity trends. Adherence to predefined dilution and wetting agent performance. |
| Animal Health | Pharmaceutical, Veterinary | Narrow range of organic impurities, clarity on solvent residuals, full traceability on raw material sources. Suitability for oral and topical administration. | Multi-step purification, solvent stripping, heavy metal analysis on each batch, and stability studies under simulated use conditions. |
| Wood Preservation | Technical, Industrial Bulk | Emphasis on cost-efficiency, solubility, and ease of dissolution in treatment solutions. Moisture and granule size range to suit process dosing. | Coarse screening, bulk packaging controls, in-process assessments for dissolution rate. |
Pinpoint the downstream process: Is the Lufenuron being employed in an agricultural field spray, an oral veterinary product, or for wood structural treatments? Each route defines limits on impurity, handling requirements, and approval criteria.
Local and international compliance marks the first step in grade selection. Food chain applications mandate clear records and validated residue trials. For veterinary use, confirm the need for dossier-supported pharmaceutical production and certification.
Set impurity ceilings according to the end product—human or animal exposure requires narrower impurity profiles, while technical uses may accommodate broader bands. Communicate analytical and release requirements before bulk ordering. Specifications follow product grade, process route, and customer-specific requests.
Assess cost-benefit based on volume: Recurring crop treatment applications may justify technical or formulation grades, while specialty pharmaceuticals demand the lowest impurity and tightest analytical controls. Manufacturing strategy adapts for minimum order size and batch campaign planning.
Process validation always begins with a sample representative of the intended manufacturing lot. Analytical results and downstream trials inform batch acceptance and longer-term sourcing agreements. Customer feedback on handling or formulation steps is relayed back to production for batch fine-tuning or process adjustments.
Quality management forms the backbone of Lufenuron manufacturing here. The plant operates in compliance with a harmonized system based on internationally recognized quality norms. Internal protocols follow GMP requirements as applicable to active substances, with annual audits carried out by accredited bodies. The entire production traceability—from raw material lot entry to finished batch release—follows electronic records and mandatory logbooks. Inspection readiness and record retention periods are driven by regulatory and customer requirements.
Certification demands for Lufenuron regularly shift according to export region and downstream use. Pesticide/intermediate exports may require specific registration support or handling declarations. Agrochemical customers often request compliance statements with relevant FAO, EPA, or national substance standards. Animal health-grade supply contracts bring expectations for VICH or analogous veterinary compliance documentation. The technical team tailors certification scope to the grade, manufacturing route, and intended market, ensuring alignment with customer procurement checks.
Comprehensive batch documentation support is available for every release. This includes Certificates of Analysis with test parameters aligned to customer specifications—often HPLC, impurity profile, and moisture data. For regulated markets, extended documentation such as Process Validation Reports, Stability Protocols, or Regulatory Dossiers can be supplied upon request. Data content, test point selection, and specification limits always reflect grade, intended application, and market-specific regulatory requirements. Each batch release is accompanied by origin verification and track-and-trace records as requested by traceable procurement programs.
Our Lufenuron production strategy centers around continuous output, with manufacturing schedules calibrated to forecast and annual contract volumes. The facility maintains surplus capacity reserves to buffer seasonal surges or spot market demand. Production lines are segmented by end-use scope—technical grade, formulated products, or veterinary grade—mitigating contamination risk and enabling tailored batch sizes. Dedicated account management teams coordinate rush or off-cycle orders, supporting pragmatic adjustment of delivery volumes and replenishment cycles as dictated by customers’ inventory models.
Plant infrastructure is designed for multi-ton annual throughput, supported by in-house synthesis of key intermediates to reduce raw material supply volatility. Raw material qualification prioritizes regionally stable sources, with dual-sourcing protocols for critical precursors. Process automation and in-process analytics substantially reduce variability, and every shift documents yield, impurity trends, and critical processing parameters. Batchwise data enables traceable and consistent output across contract durations, supporting uninterrupted supply for large-volume users.
Sample requests for Lufenuron—whether for formulation development, process validation, or regulatory filing—are processed by the technical service team. Clients specify required grade, documentation scope, and intended test protocols. Sample preparation routes (e.g., direct lot draw, extra purification cycle) depend on the end-use and volume. All samples ship with representative batch documentation and, where needed, pre-shipment stability data. Hazard communication sheets and UN-compliant packaging are standard for regulated markets.
Business models are structured to fit both fixed-quantity annual agreements and rolling purchase orders. Flexible frameworks allow clients to modify allocation or shipping intervals according to real-time downstream requirements. For long-term partners, production windows can be reserved for custom grades or late-stage differentiation. Supply risk mitigation extends to shared forecast scenarios, JIT deliveries, and safety stock holding at external warehouses. Each supply mode is confirmed with technical feasibility checks and commercial negotiation, ensuring all cost, quality, and compliance terms are clear prior to contract execution.
Development efforts for lufenuron in manufacturing environments primarily focus on optimizing synthesis routes to improve yield consistency, minimize process impurities, and control residual solvents within grade-dependent limits. Teams frequently investigate alternative raw material sources for cost stability and quality traceability, as input variability directly impacts byproduct formation and downstream purification steps. Formulation R&D continues to examine improved dispersibility for suspension concentrates and better suspension retention in final end-use, with application performance studies prioritizing particle size control and crystal habit tailoring, both of which impact delivery in agricultural and veterinary applications.
Industrial partners express increasing interest in expanding lufenuron usage beyond core pesticidal and veterinary roles into grain protection, pest management in food storage, and antifouling coatings for marine equipment. Some regional regulatory environments drive adaptation toward minor crop protection uses, demanding re-validation of maximum residue limits and testing for selectivity on sensitive crops or commodities. Differences in application environment frequently require grade-specific formulation adjustments, especially for end-users focused on food chain or animal safety compliance.
Batch consistency in lufenuron synthesis relies on stringent in-process control of chlorination steps and byproduct suppression. Each process route can introduce characteristic trace impurities, making batch release hinge on downstream purification yield and robust analytical monitoring. Recent process development has yielded reductions in certain halogenated byproducts by refining solvent recovery and introduction sequences. Another challenge remains in consistently achieving micron-sized crystals for high-performance formulations, with technical gains linked to controlled crystallization and post-synthesis milling under managed thermal and moisture conditions.
Demand forecasts among core industry buyers, including multinational agrochemical groups and licensed veterinary formulators, indicate stable or slightly increased lufenuron volumes within regulated regions. Projected consumption changes depend on regulatory frameworks and shifts toward integrated pest management. Manufacturers anticipate moderate volume growth in new application segments where off-patent adoption is matched by tailored end-use registration. Competitive pricing pressures from global supply chains and changing local restrictions will continue to shape margin structures.
Synthesis routes are expected to favor cleaner, higher recovery systems with minimized solvent load and energy input. Adoption of higher purity raw materials at scale is shaping batch reproducibility, while continuous manufacturing or semi-batch process evaluation may gradually displace conventional batchwise production in high-volume installations. Formulation scientists are moving towards more robust, climate-resistant product forms, emphasizing microencapsulation and controlled-release matrices tested against field environmental stresses and broad application pH ranges.
Environmental compliance drives process engineers to reduce effluent load through recovery and recycling of solvents and catalysts. Lifecycle assessments highlight raw material origin and process emissions as primary improvement targets, prompting trials with alternative feedstocks compatible with established plant infrastructure. Green formulation research increasingly focuses on biodegradable carriers and adjuvants—especially in end-use forms destined for consumer or veterinary applications where secondary exposure remains a concern. Waste minimization is supported by in-process analytics to maximize first-time yield and lower rejected batch rates.
Technical support teams present batch-specific certificates of analysis and respond to formulation troubleshooting tied to real-world usage, such as solubility incompatibilities or sedimentation in finished suspensions. Root cause diagnostics for field application issues frequently involve joint review of raw material lot data, process records, and product sample analysis. Customers often require guidance on adapting formulation processes to accommodate region-specific requirements or raw material variations.
Support extends through pilot-scale application studies, including tests with customer-chosen adjuvants and water sources. Application recommendations differ by crop, climate, formulation vehicle, and target pest spectrum, requiring process data from actual use conditions. Feedback provided by field trial partners informs ongoing adjustment of technical parameters, such as suggested dilution ratios or compatibility with tank-mix partners, rather than generalized instructions.
Commitment to after-sales support includes investigation of any batch performance deviations, trigger-based recall protocols, and rapid engagement between end-user and on-site technical specialists. Replacement or reprocessing provisions align with deviation severity and documented root causes, with the final response determined by joint manufacturer-user review. Each product movement is traceable by batch record, ensuring accountability from raw material intake through customer delivery.
Producing lufenuron requires direct control over every stage of synthesis, purification, drying, and lot release. Our manufacturing plant integrates strict material flow, equipment maintenance, and automated controls, all geared toward delivering technical grade lufenuron with low byproduct content, stable particle characteristics, and targeted active ingredient levels. Our engineers monitor incoming raw materials and batch processes with validated assays. Each batch undergoes checks for off-odors, inconsistent color, and active content drift before packaging proceeds. Environmental emission and effluent compliance receive equal attention alongside product targets, reinforcing our accountability as an originator, not a marketer or packer.
Lufenuron stands as a key input for the formulation of pest management products used throughout crop protection, stored grain, and hygiene sectors. Manufacturers compound this material into large-volume granules, suspension concentrates, and tablets for use in both agricultural and veterinary channels. Our output supports pharmaceutical ingredient blending where precision in particle size and low impurity levels determine downstream yield. Industrial buyers utilize our lufenuron in animal feed premixes and oral dosage forms for flea and tick control, where batch-to-batch reliability remains critical to safety compliance and regulatory approval processes.
The value of committing to a direct manufacturer shows up in process transparency. Our QC laboratory releases only batches achieving sharp assay range, controlled water content, and minimal organoleptic deviation. Our plant applies both in-process and end-point analytics—HPLC, moisture determination, retention time calibration—to avoid fluctuations that would complicate downstream processing. We revisit process parameters after any anomaly flagged in the plant log, immediately running comparison trials. Routine sample retention ensures traceability. No private labeler or broker accounts for this degree of production oversight when guaranteeing functional consistency.
Industrial users rely on bulk supply for continuous formulation runs and maintenance-free logistics. We deliver lufenuron in certified fiber drums, lined cartons, and FIBCs sized for high-volume users, sealed for atmospheric resistance and traceable with production codes. Our production lines fill bulk packs on demand from GMP-controlled storage rooms that prevent cross contamination. Unlike traders, we configure load scheduling, palletization method, and documentation tailored for direct shipment to plant warehouses or contract manufacturers. Controlled supply, originating from the factory making the product, shields buyers from batch delays, storage damage, and reconditioning risks.
Direct access to the manufacturing team translates into technical support grounded in operational knowledge, not just written statements. Our project engineers support industrial partners on scale-up, suspension stability, and custom micronization needs based on firsthand production data. Clients benefit from method transfer experience and troubleshooting assistance covering compatibility, dissolution, and regulatory batch sampling. We analyze test feedback and recommend plant-level process adaptations based on real-time production outcomes, not theory. Direct dialogue shortens turnaround and curtails guesswork in commercial trials.
Sourcing lufenuron from the actual factory eliminates procurement chain ambiguities, unreported repackaging, and batch mixing. Industrial buyers maintain price visibility, minimize secondary storage, and reduce compliance audit risks. Deliveries originate from our site, with documentation referencing our production records, not a third-party declaration. This gives manufacturers and distributors a clear cost basis and supports regulatory inspection. Procurement teams benefit from reduced negotiation cycles, forward contract options, and technical integration anchored in factory process parameters. Consistency, origin traceability, and expert support define the genuine manufacturer’s advantage in the industrial chemical value chain.
Years of manufacturing Lufenuron have shown us how important it is to understand not only what a product does, but how it does it. In pest control, mode of action shapes both the outcome in the field and the confidence our technical team delivers to every customer. Lufenuron takes a targeted approach—one that exploits a very specific vulnerability in insect biology without relying on broad-spectrum toxicity.
As producers, we closely track how our process delivers purity and consistency, because the function of Lufenuron centers on disrupting chitin production in insects. Insects need chitin as a structural building block for their exoskeletons. Without the ability to synthesize chitin correctly, developing insects cannot properly molt or form a protective shell. This selective action means our Lufenuron targets immature stages—larvae and nymphs—breaking the pest lifecycle from within. What sets Lufenuron apart from many older chemistries is its focus: rather than paralyzing adult pests or disrupting the entire nervous system, it quietly undermines the next generation before damage compounds or populations explode.
Listening to our long-term industrial users, we see that Lufenuron fits especially well alongside other pest control strategies. Since it does not cause rapid knockdown of adult insects, it does not exert pressure that often leads to resistance as quickly as contact poisons. Many operators appreciate how it can be part of a rotation program, reducing the burden on more aggressive actives. In manufacturing, we pay close attention to maintaining consistent particle size and dispersibility, so our product can be safely and precisely metered into a variety of applications, from crops to stored products to veterinary use.
This selective action also supports environmental safety goals. Extensive feedback from partners in agriculture and public health tells us that Lufenuron’s low toxicity toward mammals, birds, and beneficial insects such as bees encourages responsible use. Its mode of action—targeting a biosynthetic step unique to insects—enables operators to treat infestations with a lower risk profile. This advantage presses us to meet stringent production standards to keep impurities in check, because trace contaminants can undermine both performance and safety.
As with any insect growth regulator, over-reliance on a single approach can eventually drive resistance. We encourage technical users to integrate alternating chemistries into their programs where feasible, as this maintains long-term effectiveness. Our technical support team provides ongoing advice to stewardship leaders and agronomists about application rates and timing to align with local pest pressures and environmental conditions. Training on proper mixing and handling also ensures field results match expected outcomes.
Our commitment as a direct manufacturer means we incorporate ongoing customer and field data into every production cycle. By understanding exactly how our Lufenuron performs in different pest ecosystems, we refine our quality control targets to meet real-world needs. The foundation always remains the mode of action—disrupt chitin synthesis and break the pest lifecycle with precision—supported by robust manufacturing that consistently delivers product designed for direct industrial use.
Lufenuron plays a key role in crop protection and veterinary applications, and its bulk supply hinges on careful coordination between our manufacturing lines and logistics team. We’ve worked with both multinational formulators and specialized agricultural companies, and understand how minimum order quantity (MOQ) and lead time shape project planning and market commitments.
Our MOQ for Lufenuron aligns with the factory’s batch processing standards and the realities of chemical storage and transport regulations. Running a production batch below a certain threshold raises costs, risks cross-contamination, and often creates more waste. We set our most common MOQ at the level of a full pallet load—often around 200 kilograms, packed in sealed fiber drums or high-density IBCs, depending on whether you require technical powder or a formulated concentrate. For larger-scale clients integrating Lufenuron into finished goods or contract manufacturing programs, we regularly prepare full container loads, which streamline customs clearance and shipping efficiency.
By standardizing bulk minimums, we also stabilize raw material purchasing and help customers lock in more predictable pricing. Smaller, fragmented orders lead to shifting schedules and increased overheads. Focusing on substantial batch sizes allows our engineers to plan for quality consistency, and our QA team to monitor traceability with every outgoing lot.
Our standard production lead time for Lufenuron bulk orders averages between three to four weeks, counting from receipt of a confirmed purchase order and pre-shipment instructions. This timeframe reflects the realities of chemical synthesis: multi-stage reactions, solvent recovery, purification, drying, and final packaging. Our reactors operate on a set campaign schedule, rotating between main products and validated ancillary runs. If demand surges during peak agricultural seasons or regulatory updates require formula adjustments, lead times may briefly extend. We always keep our partners updated on order status through every stage.
We know downstream projects and market launches rely on secure timing. To avoid unpredictable delays, our team sources core raw materials under rolling contracts, especially the active pharmaceutical intermediates that can swing costs or cause bottlenecks if markets shift. For ongoing partners planning multi-month campaigns, we offer contractual production slots and reserve warehouse capacity for scheduled call-offs.
Unexpected demand spikes or late-stage tenders often drive requests outside our usual MOQ and schedule. Our technical leadership reviews each case individually. If we have surplus inventory or the next campaign is on standby, we can pull forward batches or offer spot shipment on shorter notice. We maintain compliance with in-country regulations and pay close attention to export paperwork, so product gets released without avoidable customs hold-ups.
Critical to supporting scalable and urgent projects is open communication. Accurate forecasts enable our line leaders to optimize scheduling at both lab and plant level. When we partner with major clients over several seasons, we can dedicate fixed slot capacity, pre-register products for rapid customs clearance, and shorten total lead time through coordinated planning. Our continuous improvement policies drive not just internal efficiencies, but also reduce wait times in both global and emerging markets.
Lufenuron bulk order management requires cooperation between manufacturing, supply chain, regulatory, and commercial teams. We invite partners to share their needs and production schedules early. With clear input, we can consistently meet demanding market timelines and minimize risk from supply interruptions or order fragmentation.
We manufacture lufenuron from raw synthesis through finished formulation, so shipping across borders stays front and center in our daily operations. Over the past decade, our teams have shipped bulk shipments to regions on six continents. Regulations tied to active pharmaceutical ingredients like lufenuron change from country to country. Customs and port authorities hold our paperwork to high scrutiny. Experience cuts through the guesswork, since missing a regulatory step quickly results in shipment holds and business losses.
No single global law governs the export of lufenuron. Each country sets its own regulatory entry list, and we monitor these requirements as part of production planning. In the European Union, lufenuron must appear on the latest approved active substance list under relevant biocide and veterinary drug regulations. Importers usually require a certificate of analysis, batch traceability records, and SDS translated into the language of the destination port. In Latin American countries, importers often request full registration certificates, proof of origin, and in some jurisdictions, prior authorization from agricultural or pharmaceutical ministries. Our shipments to Asia frequently come with additional scrutiny—the customs authorities in China, South Korea, and Japan request extensive technical data on the compound, packaging, and even analytical test methods.
Customs authorities treat insecticides and anti-flea veterinary APIs as high watchpoint shipments. Without local documentation or recognized registration, the product may be blocked at the border, inspected, or even deported. We produce and maintain complete technical and regulatory files, including copies of GMP certificates and process flow diagrams, to head off such delays.
Every shipment from our plants leaves with a bill of lading, signed certificate of origin, compliant safety data sheet, and details on packaging and net weight. Besides general shipping and insurance paperwork, most import regulations demand a manufacturer’s declaration listing the product composition, intended use, and batch numbers. Some markets, especially those regulating lufenuron as a drug precursor, require legalizations from trade consulates or proof of prior regulatory approval.
We often encounter requests for compliance with international standards such as REACH in the European Union or EPA’s FIFRA standards for the United States. Registration numbers enter the paperwork and, for specific destinations, site audit records proving site quality and traceability are submitted. To minimize risk, our logistics staff review all regulatory letters, ensuring the right country-specific formatting appears on covering documents. We have learned from experience that errors or omissions mean shipments stand idle in customs warehouses, with material subject to fines or re-export orders.
The regulatory landscape shifts with every update from national ministries or international chemical safety authorities. We keep compliance teams in-house and maintain working relationships with customs brokers in major destination ports. Our technical team assembles real-time data packages and scans import trends. To overcome administrative bottlenecks—especially in countries with slow permit cycles—we provide electronic as well as hardcopy documentation. We stay prepared to supply traceability records, stability studies, and production process clarifications whenever customs officers demand supporting materials onsite.
Thorough preparation and responsive communications have become our best strategy. Our staff applies decades of shipment experience to avoid regulatory setbacks, and we collaborate with receiving companies to clarify any questions promptly. As direct producers, we treat every shipment as a showcase of both our manufacturing quality and our commitment to meeting global compliance standards.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales3@ascent-chem.com, +8615365186327 or WhatsApp: +8615365186327
